<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.TrialResultsInput xmlns:ns2="local"><filtersEnabled>0</filtersEnabled><hits>20</hits><offset>0</offset><query>"A randomized, flexible-dose, rater-blind, parallel-group, quasi-naturalistic trial comparing the efficacy, safety, and tolerability of quetiapine, risperidone, and olanzapine in patients with schizophrenia hospitalized for severe psychotic symptoms"</query><queryLanguage>ssql</queryLanguage></ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.TrialResultsInput>